Kirsti Gjellan - Swedish Orphan Insider

BIOVF -- USA Stock  

USD 21.80  0.000001  0.00%

Senior Vice President Manufacturing Operations

Ms. Kirsti Gjellan serves as Senior Vice President, Head of Biologics Development Supply at Swedish Orphan Biovitrum AB . She joined the Company in 2014. She is Pharmacist and holds a Doctorate of Philosophy degree in Pharmaceutical Technology from Universitetet i Oslo. Previously she was Factory Director, Biologics Manufacturing, MD at Pfizer Health AB and Board Member of Pfizer Health AB . She was also Director of Quality Operations, Pfizer . She has 17 years of experience from senior positions in research and manufacturing medicines at Astra Zeneca. She is also Board member of Processindustriell IT and Automation .
Age: 53        
46 86 97 20 00  http://www.sobi.com

Management Efficiency

The company has return on total asset (ROA) of 11.67 % which means that it generated profit of $11.67 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 22.83 % meaning that it generated $22.83 on every $100 dollars invested by stockholders.
The company has accumulated 714.78 K in total debt. Swedish Orphan Biovitrum AB has Current Ratio of 1.85 which is within standard range for the sector.

Similar Executives

Entity Summary

Swedish Orphan Biovitrum AB , an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. Swedish Orphan Biovitrum AB is headquartered in Solna, Sweden. Swedish Orphan is traded on OTC Market in USA.Swedish Orphan Biovitrum AB (BIOVF) is traded on OTC Market in USA. It is located in Tomtebodav?gen 23A and employs 816 people.

Swedish Orphan Biovi Leadership Team

Hans Wigzell, Director, Ph.D
Lennart Johansson, Director, MBA
Annette Clancy, Director
Trista Morrison, President
Kirsti Gjellan, President
Jorgen Winroth, VP
Milan Zdravkovic, President, Ph.D
Hans Schikan, Director
Dennis Pedersen, President
Helena Saxon, Director, MBA
Anders Edvell, Executive, MBA
Geoffrey McDonough, CEO, Ph.D
Lars Dreioee, President, MBA
Alan Raffensperger, COO
Fredrik Berg, Executive
BoGunnar Rosenbrand, Director
Adine Axen, Director
Birgitte Volck, President
MatsOlof Wallin, President
Stefan Fraenkel, President, MBA
Hakan Bjorklund, Chairman, Ph.D
Cecilia Forberg, President
Stephen James, President, Ph.D
Bo Hansen, Chairman, Ph.D
Armin Reininger, President, Ph.D
Catarina Larsson, Director
David Allsop, Director
Elisabeth Svanberg, Director
Wills HughesWilson, President
Guido Oelkers, CEO
Jeffrey Jonas, Director, Ph.D
Matthew Gantz, Director, MBA
Theresa Heggie, Director

Stock Performance Indicators

Did you try this?

Run Alpha Finder Now
   

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
All  Next Launch Alpha Finder

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Swedish Orphan and Facebook. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Pair Correlation module to compare performance and examine historical correlation between any two equity instruments.